Crystal Rock Capital Management Purchases 4,460 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Crystal Rock Capital Management increased its Intuitive Surgical stake by 52.9% in the third quarter, buying 4,460 shares for a total of 12,885 shares valued at approximately $5.24 million.
• Intuitive Surgical reported strong quarterly results, with revenue of $3.05 billion and EPS of $3.00, beating analyst expectations and reflecting 21.7% year-over-year revenue growth.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and $493.54 price target, although the stock’s high valuation, margin pressure and recent insider selling remain potential risks.

Crystal Rock Capital Management increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 52.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 12,885 shares of the medical equipment provider's stock after buying an additional 4,460 shares during the period. Intuitive Surgical comprises approximately 2.8% of Crystal Rock Capital Management's holdings, making the stock its 15th largest position. Crystal Rock Capital Management's holdings in Intuitive Surgical were worth $5,239,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of ISRG. North Point Portfolio Managers Corp OH bought a new stake in Intuitive Surgical during the 3rd quarter valued at approximately $27,000. John Boyer Inc. purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $27,000. Compass Wealth Management LLC purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $29,000. Main Street Group LTD bought a new position in Intuitive Surgical in the 1st quarter worth approximately $30,000. Finally, Compass Financial Management LLC bought a new position in Intuitive Surgical in the 2nd quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported quarterly revenue of $3.05 billion, above the $2.91 billion consensus estimate, and earnings of $3.00 per share versus expectations of $2.65. The earnings beat supports the long-term growth outlook for its robotic-surgery platforms. ISRG Sales Growth Article
• Positive Sentiment: Analyst sentiment remains favorable. ISRG carries a “Moderate Buy” consensus rating, with an average price target of $493.54; Baird raised its target to $550 and maintained an outperform rating, while other firms reiterated bullish views.
• Positive Sentiment: Institutional ownership is high at 83.64%, and several large investors—including Bank of America, Amundi, Arrowstreet Capital and Janus Henderson—recently increased their positions, providing a supportive ownership backdrop.
• Neutral Sentiment: Investors are weighing whether ISRG’s premium valuation is justified. The stock has rebounded over the past one to three months but remains below its prior-year level, leaving the sustainability of procedure growth and earnings estimates as key issues.
• Negative Sentiment: Profitability remains a concern: commentary pointed to lower net income and earnings per share despite higher revenue, indicating margin pressure. With the shares trading at a high earnings multiple, any slowdown in procedures, pricing or margins could create volatility.
• Negative Sentiment: Several insiders reported sales, including former CEO Gary Guthart, Fredrik Widman and EVP Mark Brosius. Brosius sold shares in two transactions, while Guthart’s sale was substantially larger. The trades were conducted under pre-arranged Rule 10b5-1 plans, reducing their signaling value, but the selling may weigh modestly on sentiment. ISRG Insider Sales

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Mark Brosius sold 61 shares of the firm's stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $441.60, for a total value of $26,937.60. Following the completion of the sale, the executive vice president directly owned 581 shares in the company, valued at $256,569.60. This trade represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 38,778 shares of company stock valued at $16,814,967 over the last three months. Company insiders own 0.60% of the company's stock.

Analyst Ratings Changes

A number of brokerages have issued reports on ISRG. HSBC lowered shares of Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price objective for the company. in a report on Thursday, July 30th. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Wednesday, October 21st. Barclays restated an "overweight" rating and set a $500.00 target price (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Piper Sandler reaffirmed an "overweight" rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Finally, Evercore set a $430.00 target price on shares of Intuitive Surgical in a research note on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $493.54.

Intuitive Surgical Price Performance

Shares of ISRG opened at $448.76 on Friday. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a 50-day moving average of $400.39 and a 200 day moving average of $434.76. The firm has a market capitalization of $155.56 billion, a price-to-earnings ratio of 49.80, a PEG ratio of 3.06 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion for the quarter, compared to analysts' expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. Intuitive Surgical's revenue was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.40 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.